BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3206137)

  • 1. [Treatment of myasthenia].
    Fève JR
    Rev Prat; 1988 Oct; 38(22):1541-5. PubMed ID: 3206137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of myasthenia gravis].
    Jerusalem F
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current therapy of myasthenia].
    Zumstein V; Regli F
    Rev Med Suisse Romande; 1985 Apr; 105(4):331-8. PubMed ID: 4012144
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of myasthenia gravis.
    Schwendimann RN; Burton E; Minagar A
    Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic considerations in myasthenia gravis].
    Vejvalka J
    Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of myasthenia gravis--pathophysiological evaluation of various forms of treatment and practical aspects of therapy (author's transl)].
    Ito N
    No To Shinkei; 1980 Sep; 32(9):921-9. PubMed ID: 7437165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapies of myasthenia gravis (author's transl)].
    de Crousaz G
    Schweiz Rundsch Med Prax; 1978 Jan; 67(4):113-7. PubMed ID: 202937
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing patients who have myasthenia gravis.
    Johns TR
    West J Med; 1985 Jun; 142(6):810-3. PubMed ID: 4024633
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of patients with myasthenia gravis.
    Sanders DB; Scoppetta C
    Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis].
    Takamori S
    Naika; 1970 Jun; 25(6):1322-7. PubMed ID: 4914457
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of myasthenia gravis.
    Lancet; 1972 Apr; 1(7754):780-1. PubMed ID: 4111252
    [No Abstract]   [Full Text] [Related]  

  • 12. [Juvenile myasthenia gravis].
    Ohno K; Sahashi K
    Ryoikibetsu Shokogun Shirizu; 2001; (36):340-3. PubMed ID: 11596404
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of plasmapheresis in combined treatment of patients with severe form of generalized myasthenia].
    Zaĭtsev VT; Krivoruchko IA; Klimova EM; Bondarenko TN; Florikian AK; Nechitaĭlo PE; Zhurov IuE; Shaposhnikov GA; Asanbaev AF
    Klin Khir (1962); 1994; (4):33-5. PubMed ID: 7799584
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmapheresis: a new treatment modality for the patient with severe myasthenia gravis.
    Eppel M; Streib EW
    Nebr Med J; 1982 Apr; 67(4):72-4. PubMed ID: 7088214
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myasthenia gravis. Treatment].
    Somnier FE
    Ugeskr Laeger; 1984 Jan; 146(5):345-8. PubMed ID: 6719608
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of myasthenia gravis].
    Gajdos P
    Presse Med; 1989 Oct; 18(35):1732-4. PubMed ID: 2531386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myasthenia gravis. Recent findings and their therapeutic consequences].
    Thümler R; Haferkamp G
    Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
    [No Abstract]   [Full Text] [Related]  

  • 19. Current treatment of myasthenia gravis.
    Osterman PO
    Prog Brain Res; 1990; 84():151-61. PubMed ID: 2267293
    [No Abstract]   [Full Text] [Related]  

  • 20. Ocular myasthenia gravis.
    Gilbert ME; Savino PJ
    Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.